Strata Oncology is a precision medicine company that provides no-cost tumor sequencing to advanced cancer patients and a portfolio of matching clinical trials. With the goal to sequence 100,000 advanced cancer patients starting in 2017, the company's mission is to match patients to the right clinical trials and to accelerate the approval and availability of precision medicines for cancer.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 06/02/16 | $12,000,000 | Series A |
Arboretum Ventures Baird Capital Michigan eLab | undisclosed |
| 05/24/18 | $26,000,000 | Series B |
Arboretum Ventures Baird Capital Deerfield Management Company, L.P. Merck Global Health Innovation Fund Pfizer Venture Investments Renaissance Venture Capital Fund | undisclosed |
| 07/28/21 | $90,000,000 | Series C |
Arboretum Ventures Baird Capital Cormorant Asset Management Deerfield Management Company, L.P. Highside Capital Management Merck Global Health Innovation Fund Monashee Investment Management Pfizer Venture Investments Renaissance Venture Capital Fund Wellington Management Company  | undisclosed |
